139 related articles for article (PubMed ID: 21838459)
1. High-dose melphalan and autologous stem cell transplantation for AL amyloidosis: recent trends in treatment-related mortality and 1-year survival at a single institution.
Seldin DC; Andrea N; Berenbaum I; Berk JL; Connors L; Dember LM; Doros G; Fennessey S; Finn K; Girnius S; Lerner A; Libbey C; Meier-Ewert HK; O'Connell R; O'Hara C; Quillen K; Ruberg FL; Sam F; Segal A; Shelton A; Skinner M; Sloan JM; Wiesman JF; Sanchorawala V
Amyloid; 2011 Jun; 18 Suppl 1(Suppl 1):127-9. PubMed ID: 21838459
[TBL] [Abstract][Full Text] [Related]
2. High-dose melphalan with autologous stem cell transplantation after VAD induction chemotherapy for treatment of amyloid light chain amyloidosis: a single centre prospective phase II study.
Perz JB; Schonland SO; Hundemer M; Kristen AV; Dengler TJ; Zeier M; Linke RP; Ho AD; Goldschmidt H
Br J Haematol; 2004 Dec; 127(5):543-51. PubMed ID: 15566357
[TBL] [Abstract][Full Text] [Related]
3. Regression of cardiac wall thickness following chemotherapy and stem cell transplantation for light chain (AL) amyloidosis.
Meier-Ewert HK; Sanchorawala V; Berk J; Finn KT; Skinner M; Seldin DC; Ruberg FL
Amyloid; 2011 Jun; 18 Suppl 1():130-1. PubMed ID: 21838460
[No Abstract] [Full Text] [Related]
4. Treatment with oral melphalan plus dexamethasone produces long-term remissions in AL amyloidosis.
Palladini G; Russo P; Nuvolone M; Lavatelli F; Perfetti V; Obici L; Merlini G
Blood; 2007 Jul; 110(2):787-8. PubMed ID: 17606766
[No Abstract] [Full Text] [Related]
5. Microbiologically documented infections in patients undergoing high-dose melphalan and autologous stem cell transplantation for the treatment of light chain amyloidosis.
Taimur S; Nader C; Lloyd-Travaglini C; Seldin DC; Sanchorawala V
Transpl Infect Dis; 2013 Apr; 15(2):187-94. PubMed ID: 23279695
[TBL] [Abstract][Full Text] [Related]
6. High-dose melphalan and autologous stem cell transplantation for systemic light-chain amyloidosis: a single institution retrospective analysis of 40 cases.
Tsukada N; Ikeda M; Shingaki S; Miyazaki K; Meshitsuka S; Yoshiki Y; Abe Y; Suzuki K
Int J Hematol; 2016 Mar; 103(3):299-305. PubMed ID: 26703787
[TBL] [Abstract][Full Text] [Related]
7. Indications for high-dose chemotherapy with autologous stem cell support in patients with systemic amyloid light chain amyloidosis.
Schonland SO; Perz JB; Hundemer M; Hegenbart U; Kristen AV; Hund E; Dengler TJ; Beimler J; Zeier M; Singer R; Linke RP; Ho AD; Goldschmidt H
Transplantation; 2005 Sep; 80(1 Suppl):S160-3. PubMed ID: 16286897
[TBL] [Abstract][Full Text] [Related]
8. High-dose melphalan and autologous stem-cell transplantation in patients with AL amyloidosis: an 8-year study.
Ann Intern Med; ; . PubMed ID: 14734330
[TBL] [Abstract][Full Text] [Related]
9.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
10.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
